KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹51 Cr | ₹27 Cr | ₹61 Cr | ₹62 Cr | ₹21 Cr |
What is the latest Consolidated Net Profit of KOPRAN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹51 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹21 Cr |
How is Consolidated Net Profit of KOPRAN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹51 Cr | 87.11 | |
| Mar2024 | ₹27 Cr | -55.38 | |
| Mar2023 | ₹61 Cr | -0.93 | |
| Mar2022 | ₹62 Cr | 193.08 | |
| Mar2021 | ₹21 Cr | - | |
Compare Consolidated Net Profit of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹643.1 Cr | 2.5% | 4.8% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 2.5% |
4.8% |
-29.5% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses